Ideas to action: independent research for global prosperity
Research
Innovative, independent, peer-reviewed. Explore the latest economic research and policy proposals from CGD’s global development experts.
CGD NOTES
May 31, 2024
CGD NOTES
June 05, 2024
CGD NOTES
May 23, 2024
WORKING PAPERS
June 05, 2024
All Research
Filters:
Experts
Facet Toggle
Topics
Facet Toggle
Publication Type
Facet Toggle
Time Frame
Facet Toggle
Research
PUBLICATION
June 10, 2024
Gavi’s new CEO, Dr. Sania Nishtar, has taken the helm at a critical time. Gavi is embarking on its new five-year strategy, known as "Gavi 6.0," and preparing to launch its next replenishment campaign.
To help shape the new CEO’s agenda, the Center for Global Development has curated a new virtual ...
CGD NOTES
May 07, 2024
IDA faces many headwinds—difficult aid politics in key donor countries; a high-interest rate environment that renders its financial model less efficient; and deteriorating credit quality in many of its client countries that makes risk taking less appealing. Breaking the $100 billion mark is not a po...
CGD NOTES
April 30, 2024
Corporal punishment is legal in many countries. Corporal punishment in schools remains legal in 63 countries. Implementing and enforcing legislation that prohibits corporal punishment across all settings is an important step towards keeping children safe. But, how far does the passing of legislation...
POLICY PAPERS
April 08, 2024
The global locus of undervaccination is increasingly shifting from the poorest countries in the world—which are eligible for support from Gavi, the Vaccine Alliance—to middle-income countries (MICs) that do not qualify for traditional Gavi support. Given these growing challenges, Gavi must rethink i...
WORKING PAPERS
April 02, 2024
Starting in 2001, duty-free access to U.S. markets under the African Growth and Opportunity Act (AGOA) led to a brief boom in African manufacturing exports, particularly apparel, which then fizzled in the face of unfettered Chinese competition after 2005. The looming expiration of AGOA—and eroding C...
WORKING PAPERS
February 22, 2024
Antibiotic resistance (ABR) already contributes to almost five million deaths per year. Without action, this number will likely rise substantially. We provide the first comprehensive assessment of the economic drivers of ABR, arguing that ABR in large part arises from extensive unresolved market (an...
POLICY PAPERS
January 30, 2024
For nearly 25 years, Gavi has delivered impact and value for money and remained one of the most successful global health initiatives. Gavi’s success has been driven by its use of three primary levers: (1) accelerating new vaccine introductions, (2) increasing equitable immunization coverage, and (3)...